PVI
TTOO

Pura Vida Investments’s T2 Biosystems, Inc TTOO Stock Holding History

Pura Vida Investments’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-30
Closed -$1.16M – 137
2018
Q2 		$1.16M Buy
+30
New +$1.14M 0.47% 66
2016
Q4 		– Sell
-12
Closed -$441K – 98
2016
Q3 		$441K Buy
+12
New +$394K 0.13% 81

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pura Vida Investments's TTOO Position: Q3 2018 in Review

Pura Vida Investments sold out of T2 Biosystems, Inc (TTOO) in Q3 2018, closing a stake of 30 shares — an estimated $1.16M sold.

Pura Vida Investments first reported a position in TTOO in Q3 2016 and held it in 2 quarters. The position peaked at $1.16M in Q2 2018. 85 funds tracked by Wall St. Rank hold TTOO as of Q3 2018.

  • Pura Vida Investments reported no remaining T2 Biosystems, Inc position as of Q3 2018 after selling out during the quarter.
  • Pura Vida Investments sold 30 T2 Biosystems, Inc shares in Q3 2018, an estimated $1.16M.
  • Pura Vida Investments first reported a position in T2 Biosystems, Inc in Q3 2016 and held it in 2 quarters.
  • Pura Vida Investments's T2 Biosystems, Inc position peaked at $1.16M in Q2 2018.
  • 85 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2018.

Based on Pura Vida Investments's 13F filing for Q3 2018, filed 14 Nov 2018.